Idiopathic Myelofibrosis
7 clinical trials · Condition
◉ Watch Idiopathic Myelofibrosis
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors (NCT02440685) | Asana BioSciences | 2015-05-01 |
| Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis (NCT01433445) | Novartis Pharmaceuticals | 2011-11-01 |
| Familial Myeloproliferative Disorders (NCT00666289) | Icahn School of Medicine at Mount Sinai | 2008-03-01 |
| Research Tissue Bank (NCT00666549) | Icahn School of Medicine at Mount Sinai | 2007-09-01 |
| Correlative Biomarker Study in Patients With Myeloproliferative Disorders (NCT00665067) | Icahn School of Medicine at Mount Sinai | 2007-04-01 |
| Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders (NCT00433862) | National Institutes of Health Clinical Center (CC) | 2007-02-06 |
Track Idiopathic Myelofibrosis automatically
Every clearance here is in the API, with alerts when new ones post.